TrialJournal of clinical hypertension (Greenwich, Conn.)2010

Effects of pioglitazone and metformin fixed-dose combination therapy on cardiovascular risk markers of inflammation and lipid profile compared with pioglitazone and metformin monotherapy in patients with type 2 diabetes.

Alfonso Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.